| Financial Year |
March 31 2023 |
| Monetary Funds |
1,567,885,602.23 |
| Held-for-trading Financial Assets |
2,947,804,376.46 |
| Notes Receivable |
-- |
| Accounts Receivable |
297,836,083.39 |
| Advances to Suppliers |
776,944.59 |
| Other Receivables |
16,727,657.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
842,802,721.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,742,183.93 |
| Total Current Assets |
5,685,575,569.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
65,838,651.05 |
| Under-construction Projects |
11,558,321.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
163,148,018.98 |
| R&D expenses |
-- |
| Goodwill |
10,561,379.62 |
| Long-Term Deferred and Prepaid Expenses |
5,902,362.16 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
232,275,339.53 |
| Sub-Total of Non-Current Assets |
526,864,319.00 |
| Total Assets |
6,212,439,888.66 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
138,311,580.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,859,948.95 |
| Taxes Payable |
1,448,290.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,836,401.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,580,678.53 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
228,076,802.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,367,033.13 |
| Total Liabilities |
244,443,836.00 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
5,200,163,717.40 |
| Surplus Reserve |
60,000,000.00 |
| LESS:Treasury Stock |
48,095,568.50 |
| Undistributed Profits |
635,026,681.05 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,967,996,052.66 |
| Owner's Equity（Stockholder's Equity） |
5,967,996,052.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,212,439,888.66 |
